Randomized phase II/III trial of veliparib or placebo in combination with adjuvant temozolomide in newly diagnosed glioblastoma (GBM) patients with MGMT promoter hypermethylation (Alliance A071102).
Tumor classification systems provide the language that allows teams of physicians and health care workers to communicate clearly about neoplasms, their natural histories, and their likely responses to ...
Muscle injury classification systems for hamstring injuries have evolved to use anatomy and imaging information to aid management and prognosis. However, classification systems lack reliability and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results